Can delusions be self-assessed? Concordance between self- and observer-rated delusions in schizophrenia

Psychiatry Research

Volumn 178, Issue 2, 2010, Pages 249-254

  Lincoln, Tania Marie ^a   Ziegler, Michael ^a   Lüllmann, Eva ^a   Müller, Matthias J ^b   Rief, Winfried ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Assessment; Delusions; Insight; Observer ratings; Self ratings

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; GRANDIOSE DELUSION; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MEMORY; OBSERVER RATED DELUSION; OBSERVER VARIATION; OUTPATIENT; PATIENT RATED DELUSION; PERSECUTORY DELUSION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RATING SCALE; SCHIZOPHRENIA; SELF EVALUATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHECKLIST; DELUSIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSERVATION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; YOUNG ADULT;

EID: 77953808926     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.04.019     Document Type: Article

References (46)

1. Ackermann R., DeRubeis R.J. Is depressive realism real?. Clinical Psychology Review 1991, 11:565-584.
2. APA Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. (4th ed.).
3. Bell V., Halligan P.W., Ellis H.D. Diagnosing delusions: a review of inter-rater reliability. Schizophrenia Research 2006, 86:76-79.
4. Bell M., Fiszdon J., Richardson R., Lysaker P.H., Bryson G. Are self-reports valid for schizophrenia patients with poor insight? Relationship of unawareness of illness to psychological self-report instruments. Psychiatry Research 2007, 151:37-46.
5. Bottlender R., Jäger M., Kunze I., Groll C., Borski I., Möller H.J. Negative Symptome schizophrener Patienten aus der Perspektive der Psychiater, der Patienten selbst und deren Angehörigen [Negative symptoms of patients with schizophrenia from the perspective of the psychiatrists, the relatives and the patients themselves]. Nervenarzt 2003, 74:762-766.
6. Cohen J. A power primer. Psychological Bulletin 1992, 112:155-159.
7. Cooke M.A., Peters E., Kuipers E., Kumari V. Disease, deficit or denial? Models of poor insight in psychosis. Acta Psychiatrica Scandinavica 2005, 112:4-17.
8. Derogatis L.R. Brief Symptom Inventory (BSI). Administration, Scoring and Procedures Manual (3 ed.) 1993, National Computer Services, Minneapolis.
9. Dixon M.J., King S. The concordance between symptom information gathered from remitted schizophrenic patients and their relatives. Journal of Psychiatric Research 1995, 29:447-456.
10. Dixon M., King S., Steiger H. The contribution of depression and denial towards understanding the unawareness of symptoms in schizophrenic out-patients. British Journal of Medical Psychology 1998, 71:85-97.
11. Domken M., Scott J., Kelly P. What factors predict discrepancies between self and observer ratings of depression?. Journal of Affective Disorders 1994, 31:253-259.
12. Enns M.W., Larsen D.K., Cox B.J. Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. Journal of Affective Disorders 2000, 60:33-41.
13. Freeman D., Garety P.A., Bebbington P.E., Smith B., Rollinson R., Fowler D., Kuipers E., Ray K., Dunn G. Psychological investigation of the structure of paranoia in a non-clinical population. British Journal of Psychiatry 2005, 186:427-435.
14. Gharabawi G.M., Lasser R.A., Bossie C.A., Zhu Y., Amador X. Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. International Clinical Psychopharmacology 2006, 21:233-240.
15. Hamera E.K., Schneider J.K., Potocky M., Casebeer M.A. Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders. Schizophrenia Research 1996, 19:213-219.
16. Härting C., Markowitsch H.J., Neufeld H., Calabrese P., Deisinger K., Kessler J. Wechsler Gedächtnistest-Revidierte Fassung (WMS-R) 2000, Verlag Hans Huber, Bern.
17. Janca A., Hiller W. ICD-10 Checklists-a tool for clinicians' use of the ICD-10 classification of mental and behavioral disorders. Comprehensive Psychiatry 1996, 37:180-187.
18. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
19. Larøi F., Van der Linden M. Metacognitions in proneness towards hallucinations and delusions. Behaviour Research and Therapy 2005, 43:1425-1441.
20. Lincoln T.M. Relevant dimensions of delusions. Continuing the continuum versus category debate. Schizophrenia Research 2007, 93:211-220.
21. Lincoln T.M., Lüllmann E., Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophrenia Bulletin 2007, 33:1324-1342.
22. Lincoln T.M., Keller E., Rief W. Die Erfassung von Wahn und Halluzinationen in der Normalbevölkerung. Deutsche Adaptationen des Peters et al. Delusions Inventory (PDI) und der Launay Slade Hallucination Scale (LSHS-R) [The assessment of delusions and hallucinations in the normal population. German adaptations of the Peters et al. Delusions Inventory (PDI) and the Launay Slade Hallucination Scale (LSHS-R)]. Diagnostica 2009, 55:29-40.
23. Lincoln T.M., Peter N., Schäfer M., Moritz S. The impact of stress on paranoia. An experimental investigation of moderators and mediators. Psychological Medicine 2009, 39:1129-1139.
24. Liraud F., Droulout T., Parrot M., Verdoux H. Agreement between self-rated and clinically assessed symptoms in subjects with psychosis. The Journal of Nervous and Mental Disease 2004, 192:352-356.
25. Lysaker P., Bryson G.J., Bell M. Insight and work performance in schizophrenia. Journal of Nervous and Mental Disease 2002, 190:142-146.
26. Mintz A.R., Dobson K.S., Romney D.M. Insight in schizophrenia: a meta-analysis. Schizophrenia Research 2003, 61:75-88.
27. Morlan K.K., Siang-Yang T. Comparison of the Brief Psychiatric Rating Scale and the Brief Symptom Inventory. Journal of Clinical Psychology 1998, 54:885-894.
28. Müller M.J., Davids E. Relationship of psychiatric experience and interrater reliability in assessment of negative symptoms. Journal of Nervous and Mental Disease 1999, 187:316-318.
29. Müller M.J., Marx-Dannigkeit P., Schlösser R., Wetzel H., Addington D., Benkert O. The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G). Journal of Psychiatric Research 1999, 33:433-443.
30. Overall J.E., Gorham D.R. The Brief Psychiatric Ratings Scale. Psychological Reports 1962, 10:799-812.
31. Peters E.R., Joseph S.A., Garety P.A. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophrenia Bulletin 1999, 25:553-576.
32. Peters E., Joseph S., Day S., Garety P.A. Measuring delusional ideation: the 21-Item Peters et al. Delusions Inventory. Schizophrenia Bulletin 2004, 30:1005-1022.
33. Preston N.J., Harrison T.J. The Brief Symptom Inventory and the Positive and Negative Syndrome Scale: discriminate validity between a self-reported and observational measure of psychopathology. Comprehensive Psychiatry 2003, 44:220-226.
34. Preti A., Sardu C., Piga A. Mixed-handedness is associated with the reporting of psychotic-like beliefs in a non-clinical Italian sample. Schizophrenia Research 2007, 92:15-23.
35. Reitan R.M. Trail Making Test. Manual for Administration and Scoring 1992, Reitan Neuropsychology Laboratory, South Tucson, Arizona.
36. Rush A.J., Carmody T.J., Ibrahim H.M., Trivedi M.H., Biggs M.M., Shores-Wilson K., Crismon M.L., Toprac M.G., Kashner T.M. Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatric Services 2006, 57:829-837.
37. Schad M.U., Keshavan M.S., Tamminga C.A., Cullum C.M., David A. Neurobiological underpinnings of insight deficits in schizophrenia. International Review of Psychiatry 2007, 19:439-448.
38. Selten J.P., Wiersma D., van den Bosch R.J. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms. Comprehensive Psychiatry 2000, 41:191-196.
39. Sevy S., Nathanson K., Visweswaraiah H., Amador X. The relationship between insight and symptoms in schizophrenia. Comprehensive Psychiatry 2004, 45:16-19.
40. Tarrier N., Lewis S., Haddock G., Bentall R., Drake R., Kinderman P., Kingdon D., Siddle R., Everitt J., Leadley K., Benn A., Grazebrook K., Haley C., Akhtar S., Davies L., Palmer S., Dunn G. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. British Journal of Psychiatry 2004, 184:231-239.
41. Tewes U. HAWIE-R-Hamburg-Wechsler-Intelligenztest für Erwachsene-Revision 1991 [HAWIE-R-Hamburg-Wechsler-Intelligence-Test for Adults] 1991, Huber, Bern.
42. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine 2009, 39:179-195.
43. Verdoux H., Van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophrenia Research 2002, 54:59-65.
44. Verdoux H., Maurice-Tison S., Gay B., Van Os J., Salamon R., Bourgeois M.L. A survey of delusional ideation in primary care patients. Psychological Medicine 1998, 28:127-134.
45. Wittchen, H.U., Zaudig, M., & Fydrich, T. (1997). Strukturiertes Klinisches Interview fuer DSM-IV. Goettingen: Hogrefe.
46. Wykes T., Steel C., Everitt B., Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 2008, 34:523-537.